These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7299326)

  • 1. Dopaminergic modulation of aldosterone secretion?
    McDougall JG; Scoggins BA; Butkus A; Coghlan JP; Denton DA; Fei DT; Hardy KJ; Wright RD
    J Endocrinol; 1981 Nov; 91(2):271-80. PubMed ID: 7299326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metoclopramide on adrenal secretion in sheep: influence of dexamethasone and sodium intake.
    Cameron V; Espiner EA; Nicholls MG; Parratt S
    J Steroid Biochem; 1987 Jun; 26(6):717-21. PubMed ID: 3613572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro studies on the effect of metoclopramide on aldosterone secretion.
    Edwards CR; Al-Dujaili EA; Boscaro M; Quyyumi S; Miall PA; Rees LH
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):45-50. PubMed ID: 7438463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of direct effect of dopamine on aldosterone secretion in vivo.
    Lun S; Espiner EA; Nicholls MG; Hart DS
    Endocrinology; 1983 Jan; 112(1):60-3. PubMed ID: 6847834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanism of action of metoclopramide-induced aldosterone secretion: in vivo and in vitro studies in the sheep.
    Wilson TA; Kaiser DL; Peach MJ; Wright EM; Carey RM
    Endocrinology; 1983 Sep; 113(3):887-92. PubMed ID: 6307670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central dopaminergic regulation of aldosterone secretion in sheep.
    Huang BS; Malvin RL; Lee J; Grekin RJ
    Hypertension; 1987 Aug; 10(2):157-63. PubMed ID: 3301664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
    Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adrenal arterial infusion of P-113 on aldosterone secretion in Na-deficient sheep.
    Blair-West JR; Coghlan JP; Denton DA; Hardy KJ; Scoggins BA; Wright RD
    Am J Physiol; 1979 Apr; 236(4):F333-41. PubMed ID: 434206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and nonmodulating hypertension.
    Williams GH; Gordon MS; Stuenkel CA; Conlin PR; Hollenberg NK
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):112S-115S. PubMed ID: 2383375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dopamine in nonmodulating hypertension.
    Gordon MS; Steunkel CA; Conlin PR; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1989 Aug; 69(2):426-32. PubMed ID: 2753983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro effects of metoclopramide on aldosterone secretion in rats.
    Nagahama S; Fujimaki M; Suzuki H; Kawabe H; Saito I; Saruta T
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):589-93. PubMed ID: 6342328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alpha atrial natriuretic peptide inhibits angiotensin stimulated aldosterone biosynthesis in bovine adrenal glands.
    Frisina N; Buemi M; Lasco A; Macri I; Squadrito F
    Horm Metab Res; 1987 Jul; 19(7):309-11. PubMed ID: 2957298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies].
    Ojima M; Itoh N; Kusano Y; Yaginuma K; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):197-207. PubMed ID: 3709883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
    Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension.
    Sala C; Morganti A; Ferraris P; Ardeleani G; Venegoni P; Quorso P; Ambrosi B; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(4):S336-8. PubMed ID: 2977175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-response comparison of the actions of angiotensin II and angiotensin III in sheep.
    Blair-West JR; Coghlan JP; Denton DA; Fei DT; Hardy KJ; Scoggins BA; Wright RD
    J Endocrinol; 1980 Dec; 87(3):409-17. PubMed ID: 7452126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evidence for an indirect mechanism mediating enhanced aldosterone secretion by metoclopramide.
    Zanella MT; Bravo EL
    Endocrinology; 1982 Nov; 111(5):1620-5. PubMed ID: 6290189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.